Form D · Biotechnology
Atlee Biotech, Inc.
Del Mar, CA · CIK 0001908273
Offering snapshot reported Feb 14, 2022 · SEC filing
- Reported sold
- $250K Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 20, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2022 | Initial | $250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-433449
Simple Agreement for Future Equity
Source: Form D, filed Feb 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Atlee Solomon | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1155 Camino Del Mar #432
Del Mar, CA, 92014
Del Mar, CA, 92014